Upadacitinib (Rinvoq) is a Janus kinase inhibitor indicated for the treatment of various autoimmune diseases, such as rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, ulcerative colitis, Crohn's disease, and ankylosing spondylitis. Due to its significant efficacy, an increasing number of patients have begun using this medication.
Purchasing Channels for Upadacitinib (Rinvoq)
Overseas Purchasing
Patients may choose to consult and purchase Upadacitinib at hospital pharmacies or legitimate drugstores in countries or regions where the drug has been launched.
Since drug prices may be affected by factors such as regional differences and exchange rate fluctuations, patients need to make budgets and plans in advance before purchasing.
Purchasing through Medical Service Institutions
Patients can consult domestic overseas medical service institutions that cooperate with international pharmacies or pharmaceutical companies.
These institutions usually provide legal import channels and offer professional consultation and guidance.
Precautions for Purchasing Upadacitinib (Rinvoq)
Doctor's Prescription is Mandatory
Upadacitinib is a strictly controlled prescription drug, and no channel may sell it without a doctor's diagnosis and prescription.
Self-medication may lead to severe adverse reactions or delay in disease treatment.
Confirm Drug Indications and Dosage
Upadacitinib is available in multiple dosage forms (e.g., 15mg, 30mg, 45mg extended-release tablets and oral solution), and the required dosage varies by disease.
Before purchasing, confirm that the drug's dosage form and specification are consistent with the doctor's advice; do not arbitrarily change or adjust the dosage.
Pay Attention to Drug Storage Conditions
According to the instruction manual, Upadacitinib tablets should be stored at 2°C–25°C, and the oral solution must be used up within 60 days after opening.
When purchasing, check whether the drug packaging is intact and whether the drug is within its expiration date.
Avoid Mixing with Other Drugs
Upadacitinib has interactions with certain drugs (such as strong CYP3A4 inhibitors and immunosuppressants). When purchasing, inform doctors or pharmacists of other drugs you are currently using to avoid adverse reactions.
How to Identify the Authenticity of Upadacitinib (Rinvoq)
Check the Drug Packaging
The packaging of genuine Upadacitinib should have a clear Chinese label or an imported drug registration certificate number.
The tablet bottle should be well-sealed, and the oral solution bottle mouth should be free of damage.
The packaging should indicate the product batch number, production date, and expiration date.
Verify the Drug Appearance
Tablets:
15mg: Purple oval-shaped, engraved with "a15";
30mg: Red oval-shaped, engraved with "a30";
45mg: Yellow oval-shaped, engraved with "a45".
Oral solution: Should be a colorless to pale yellow clear liquid, with a dedicated syringe and bottle adapter attached to the bottle.
